Short answer
Zimmer Biomet (ZBH) filed its Q1 2026 10-Q quarterly report on May 1, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $2.1B (up 9.3% year over year) with net income of $238M.
Q1 2026 key financials · XBRL
- Revenue
- $2.1B
- +9.3% YoY
- Net income
- $238M
- +30.8% YoY
- Operating margin
- 17.9%
- EPS (diluted)
- $1.22
- +34.1% YoY
Source: XBRL data from the Zimmer Biomet (ZBH) Q1 2026 10-Q on SEC EDGAR. USD.
Zimmer Biomet Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No material changes identified; 2025 Form 10-K risks remain applicable
- Newly authorized $1.5 billion repurchase program, with $1.25 billion remaining as of March 31, 2026
- Additional unknown or currently immaterial risks could materially adversely affect results
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Zimmer Biomet quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.